Clinical Trials for Artificial Intelligence in Cancer Diagnosis: A Cross-Sectional Study of Registered Trials in ClinicalTrials.gov
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective: Clinical trials are the most effective way to judge the merits of diagnosis and treatment strategies. The in-depth mining of clinical trial data enables us to grasp the application trend of artificial intelligence (AI) for cancer diagnosis. The aim of this study was to analyze the characteristics of registered trials on AI for cancer diagnosis. Methods: Clinical trials on AI for cancer diagnosis registered on the ClinicalTrials.gov database were searched and downloaded. Statistical analysis was performed by using SPSS 20.0 software. Results: A total of 97 registered trials were included. Of them, only 27 (27.8%) were interventional trials and 70 (72.1%) were observational trials. Fifteen (15.4%) trials had been completed. Fifty trials were in recruitment and another 18 remained unrecruited. The number of cases included in the clinical trials tended to be large, 31 (32.0%) trials including samples ranging from 100 to 499 cases and 17 (17.5%) trials including samples ranging from 500 to 999 cases. Of the 27 interventional trials, only 2 trials reported trials’ phase. Most (85.2%) interventional trials were for diagnosis, and a few (3.7%) were for the purpose of both the diagnosis and therapy of cancers. For the observational clinical trials, 46 (65.7%) were cohort studies, and 11 (15.7%) were case-only studies. Among the observational trials, 46 (65.7%) were prospective studies and 13 (18.6%) were retrospective studies. Among 97 trials, 37 (38.1%) involved colorectal cancer, 11 (11.3%) involved breast cancer, 43 (44.3%) were for imaging diagnosis, 33 (34.0%) were for endoscopic diagnosis and 11 (11.3%) were for pathological diagnosis. For the interventional trials, eleven trials were parallel assignment (40.7%) and 14 were single group assignment (51.9%). Among the 27 interventional trials, 18 (66.7%) trials were performed without masking, 6 (22.2%) trials were performed with single masking, only 1 (3.7%) were performed with double masking, and 2 (7.4%) was performed with triple masking. Conclusion: It appears that most registered trials on AI for cancer diagnosis are observational design, and more trials are needed in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
I.—COMPUTING MACHINERY AND INTELLIGENCE
TURING, A. M. (1950) · Mind · doi:10.1093/mind/lix.236.433 · Cited by 10,290 · cited 1×
“It has been suggested that a machine is intelligent if its working behavior is indistinguishable from that of a human being (1).”
BackgroundRajkomar, A., Dean, J., & Kohane, I. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1814259 · Cited by 4,579 · cited 2×
“At present, the most critical problem for AI application in imaging is that there is no gold standard of AI for cancer diagnosis (12); thus, many researchers performed trials to assess AI for cancer diagnosis, because trials are the most effective way to judge the merits of diagnosis and treatment…”
BackgroundEhteshami Bejnordi, B., Veta, M., Johannes van Diest, P., van Ginneken, B., Karssemeijer, N., Litjens, G., van der Laak, J. A. W. M., and the CAMELYON16 Consortium, Hermsen, M., Manson, Q. F., et al. (2017) · JAMA · doi:10.1001/jama.2017.14585 · Cited by 3,293
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
Yu, K.-H., Zhang, C., Berry, G. J., Altman, R. B., Ré, C., Rubin, D. L., & Snyder, M. (2016) · Nature Communications · doi:10.1038/ncomms12474 · Cited by 972
Ström, P., Kartasalo, K., Olsson, H., Solorzano, L., Delahunt, B., Berney, D. M., Bostwick, D. G., Evans, A. J., Grignon, D. J., Humphrey, P. A., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30738-7 · Cited by 620
Chen, P.-H. C., Gadepalli, K., MacDonald, R., Liu, Y., Kadowaki, S., Nagpal, K., Kohlberger, T., Dean, J., Corrado, G. S., Hipp, J. D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0539-7 · Cited by 342
Su, J.-R., Li, Z., Shao, X.-J., Ji, C.-R., Ji, R., Zhou, R.-C., Li, G.-C., Liu, G.-Q., He, Y.-S., Zuo, X.-L., et al. (2020) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.08.026 · Cited by 286
Lost in thought—the limits of the human mind and the future of medicine
Obermeyer, Z., & Lee, T. H. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1705348 · Cited by 252 · cited 1×
“With the help of AI, doctors can provide medical services to patients more efficiently and accurately (11, 12).”
BackgroundHyun, S. H., Ahn, M. S., Koh, Y. W., & Lee, S. J. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002810 · Cited by 185 · cited 1×
“In terms of the imaging diagnosis of lung cancer, it was reported that machine learning could predict the histological type of lung cancer through the imaging characteristics of PET/CT (18).”
Background
Cited by
Deep learning in histopathology: the path to the clinic
van der Laak, J., Litjens, G., & Ciompi, F. (2021) · Nature Medicine · doi:10.1038/s41591-021-01343-4 · Cited by 902
Digital pathology and artificial intelligence in translational medicine and clinical practice
Baxi, V., Edwards, R., Montalto, M., & Saha, S. (2022) · Modern Pathology · doi:10.1038/s41379-021-00919-2 · Cited by 592
Machine learning in clinical decision making
Adlung, L., Cohen, Y., Mor, U., & Elinav, E. (2021) · Med · doi:10.1016/j.medj.2021.04.006 · Cited by 282
Hamamoto, R., Suvarna, K., Yamada, M., Kobayashi, K., Shinkai, N., Miyake, M., Takahashi, M., Jinnai, S., Shimoyama, R., Sakai, A., et al. (2020) · Cancers · doi:10.3390/cancers12123532 · Cited by 207
Artificial intelligence in colorectal surgery: an AI-powered systematic review
Spinelli, A., Carrano, F. M., Laino, M. E., Andreozzi, M., Koleth, G., Hassan, C., Repici, A., Chand, M., Savevski, V., & Pellino, G. (2023) · Techniques in Coloproctology · doi:10.1007/s10151-023-02772-8 · Cited by 38
Metadata
- Authors
- Dong, J., Geng, Y., Lu, D., Li, B., Tian, L., Lin, D., & Zhang, Y.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-09-15
- Volume
- 10
- Pages
- 1629-1629
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3092248339
- Cited by
- 47
- References
- 12
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Trials for Artificial Intelligence in Cancer Diagnosis: A Cross-Sectional Study of Registered Trials in ClinicalTrials.gov. https://app.cochat.ai/papers/10.3389/fonc.2020.01629
- The paper
- Dong, J., Geng, Y., Lu, D., Li, B., Tian, L., Lin, D., & Zhang, Y. (2020). Clinical Trials for Artificial Intelligence in Cancer Diagnosis: A Cross-Sectional Study of Registered Trials in ClinicalTrials.gov. Frontiers in Oncology. https://doi.org/10.3389/fonc.2020.01629
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.